Covidien (COV) Pharma Spin-Off Mallinckrodt Applies for NYSE Listing

February 5, 2013 8:43 AM EST Send to a Friend
Covidien (NYSE: COV) announced that Mallinckrodt plc intends to apply to list its ordinary shares on the New York Stock Exchange (NYSE) to trade under the symbol MNK.

As previously announced, Covidien plans to spin off its Pharmaceuticals business into Mallinckrodt, a stand-alone company, a process expected to be completed in mid-2013.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News

Add Your Comment